Mireli W. Fino

Biography

Ms. Fino joined Protein Sciences in 2012 as VP, Manufacturing Operations. She comes from Wyeth (now Pfizer) where she spent the past 20 years in various roles in vaccine development and commercial manufacturing, most recently as Director Manufacturing Sciences and Technology - Drug Substance.

Research Interest

She played a key role in the successful development and launch of Prevnar13® pneumococcal 13-valent conjugate vaccine, considered one of the most complex biologics licensed to date. In addition, Ms. Fino led global initiatives implementing process and yield improvements based on the successful applications of risk management and Quality by Design (QbD) and Process Analytical Technology (PAT) concepts. She has a B.S. in Biochemical Engineering from the University of Aguascalientes in Mexico.